A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study.
| Image |  |
|---|---|
| Description | scientific article published on 11 April 2018 |
| Author/s |
author: Michitaka Honda Takao Takahashi |
| Publication date | April 11, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |